Tidutamab (Anti-CD3 & SSTR2)
Tidutamab (Anti-CD3 & SSTR2) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). It can be used in neuroendocrine tumors (NETs) and small cell lung cancer (SCLC). MW :147.36 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3170 |
Sku # | A3170-1mg*25 |
Pricing | 1mg*25, $5070.00 |